Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions

P4, at concentrations equivalent to those present in the placenta and uterus, inhibit spontaneous myometrial contractility in vitro by nongenomic mechanisms.